Can Fite BioPharma Ltd (CANF)

[stocktrademan]

$CANF recent news/filings

bullish 3.4005
gapped up recently
breakout soon

## source: finance.yahoo.com

Fri, 27 Nov 2015 12:00:00 GMT ~ Can-Fite Reports Financial Results for Nine Months Ended September 30, 2015

[PR Newswire] - PETACH TIKVA, Israel, Nov. 27, 2015 /PRNewswire/ -- Can-Fite BioPharma Ltd . (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being developed to ...

read full: http://finance.yahoo.com/news/fite-reports-financial-results-nine-120000197.html
*********************************************************

Tue, 24 Nov 2015 13:10:00 GMT ~ Biotech Sector Due Diligence Report Highlights 4 Emerging Companies - Broad Street Alerts

[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 24, 2015 / Genetic Technologies Limited (NASDAQ: GENE), Can-Fite BioPharma Ltd. (NYSEMKT: CANF), KaloBios Pharmaceuticals, Inc. (NASDAQ: KBIO), and Sarepta Therapeutics, ...

read full: http://finance.yahoo.com/news/biotech-sector-due-diligence-report-131000905.html
*********************************************************

Mon, 23 Nov 2015 16:33:00 GMT ~ 4 Stocks to Watch Trading Under $500M Market Cap

[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 23rd, 2015 / StockMarketLeader.com is an investor alert service that exclusively highlights public companies on the NASDAQ & NYSE with strong upside potential. We are ...

read full: http://finance.yahoo.com/news/4-stocks-watch-trading-under-163300702.html
*********************************************************

Mon, 23 Nov 2015 15:55:00 GMT ~ CANF: CF102 Expanded into NASH


read full: http://finance.yahoo.com/news/canf-cf102-expanded-nash-155500410.html
*********************************************************

Mon, 23 Nov 2015 12:00:00 GMT ~ Can-Fite Announces Compelling Pre-Clinical Data on CF102 in the Treatment of Non-Alcoholic Steatohepatitis (NASH)

[PR Newswire] - PETACH TIKVA, Israel, Nov. 23, 2015 /PRNewswire/ -- Can-Fite BioPharma Ltd . (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory ...

read full: http://finance.yahoo.com/news/fite-announces-compelling-pre-clinical-120000497.html
*********************************************************

$CANF charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$CANF company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/CANF/company-info
Ticker: $CANF
OTC Market Place: Not Available
CIK code: 0001536196
Company name: Can-Fite Biopharma Ltd.
Company website: http://ir.canfite.com/profile
Incorporated In: NY, USA

Business Description: Can-Fite BioPharma (TASE: CFBI; OTC: CANFY) is an Israeli biopharmaceutical company with an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address autoimmune-inflammatory, cancer and ophthalmic diseases. The company platform technology utilizes the Gi protein associated A3 adenosine receptor (A3AR) as a therapeutic target. The company pipeline drugs are synthetic, highly specific agonists and allosteric modulators targeting the A3AR. All drugs are orally bioavailable with an excellent safety profile with over 1000 patients who have participated in clinical trials conducted by the company. CF101 drug candidate is in advanced clinical development for the treatment of autoimmune-inflammatory diseases, including Rheumatoid Arthritis (phase 2b) and Psoriasis (phase 3). Can-Fite holds 82% in OphthaliX Inc. which develops CF101 for ophthalmic indications, including, Glaucoma (phase 2) and Uveitis. CF102 drug candidate is being developed for the treatment of Hepatocellular Carcinoma (Primary Liver Cancer, in preparation for phase 2), under an Orphan Drug Status designated by the FDA. CF602 is Can-Fite's second generation allosteric drug candidate (pre-clinical stage) aimed at inflammatory diseases and sexual dysfunction. Can-Fite has licensed CF101 for the treatment of autoimmune diseases to Seikagaku Corporation (SKK) in Japan and for RA to Kwang Dong in Korea.Less >>

$CANF share structure

## source: otcmarkets.com

Market Value: $28,666,250 a/o Dec 01, 2015
Shares Outstanding: 16,150,000 a/o Jan 09, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$CANF extra dd links

Company name: Can-Fite Biopharma Ltd.
Company website: http://ir.canfite.com/profile

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CANF/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CANF/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CANF+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CANF+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CANF+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CANF/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CANF/news - http://finance.yahoo.com/q/h?s=CANF+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CANF/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CANF/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CANF/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CANF/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CANF/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CANF/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CANF/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CANF/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CANF+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CANF
DTCC (dtcc.com): http://search2.dtcc.com/?q=Can-Fite+Biopharma+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Can-Fite+Biopharma+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Can-Fite+Biopharma+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://ir.canfite.com/profile
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://ir.canfite.com/profile#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://ir.canfite.com/profile

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CANF/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CANF
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CANF/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CANF/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CANF/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001536196&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CANF/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CANF/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CANF/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CANF/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CANF&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CANF
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CANF/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CANF+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CANF+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CANF
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CANF
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CANF+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CANF/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CANF+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CANF.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CANF
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CANF/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CANF/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CANF/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CANF/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CANF
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CANF
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CANF:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CANF
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CANF



$CANF DD Notes ~ http://www.ddnotesmaker.com/CANF